The 11th Annual American Medical Device Summit (AMDS), hosted by the Generis Group on October 1–2, 2024, welcomed over 200 global MedTech leaders at the Renaissance Schaumburg Hotel in Chicago. This summit served as a vital platform for industry executives, innovators, and regulatory experts to delve into key insights and challenges shaping the future of medical devices.
Key Insights
A central theme of AMDS 2024 was the growing impact of advanced technologies on manufacturing and regulatory compliance. The Vice President of Innovation at a medical device company based in Ireland highlighted how artificial intelligence (AI) enhances precision and reduces production time, which is critical for companies aiming to boost efficiency and improve patient outcomes. A US-based multinational pharmaceutical and medical technologies corporation addressed regulatory challenges, emphasizing adaptable frameworks to navigate the complexities of digital health.
Johari MedTech – Driving Innovation for Global Healthcare
Johari MedTech (a Syrma SGS company) participated as a gold sponsor of the American Medical Device Summit 2024. Our leadership team—Tejas Shah, Vice President and Head of Business Development, Monali Bhansali, Head of Strategy and Growth, and Preetesh Bhandari, Head of Manufacturing and Supply Chain—underscored the company’s robust capabilities in providing total product lifecycle support. Through live demonstrations, virtual facility tours, and one-on-one meetings, we showcased our expertise as a global leader in medical device design, engineering, contract manufacturing, and regulatory services.
With over 40 years of expertise, Johari MedTech has firmly established itself as India’s preferred MedTech partner for global markets. Our robust capabilities in design, development, engineering, and manufacturing are spread across 13 locations in India.
Certified by the United States Food and Drug Administration (US FDA), International Organization for Standardization (ISO) 13485:2016, and Medical Device Single Audit Program (MDSAP), our company operates as a 100% export-oriented unit. This allows for duty-free import benefits, streamlined processes, and cost-optimization measures that ensure efficient production and time-to-market. Delegates visiting our booth at the summit recognized our strong adherence to industry standards.
An engaging Lunch & Learn Roundtable Discussion led by our experts Monali Bhansali and Preetesh Bhandari explored the critical role of agile methodologies and design for manufacturing in accelerating time-to-market. They offered attendees actionable insights to achieve this objective while effectively navigating global regulatory landscapes.
Addressing Industry Challenges
Candid discussions at the summit focused on key industry challenges, with supply chain resilience emerging as a top concern. A US-based multinational medical devices and healthcare company stressed the need to rethink sourcing strategies in light of pandemic-exposed vulnerabilities. They highlighted the necessity for flexible and scalable solutions to adapt to rapid shifts in the global landscape.
Emerging Opportunities in MedTech
Growing opportunities reshaping the medical device sector were a major focus at AMDS 2024. A US-based global innovator in medical devices and technologies for interventional medicine pointed to a trend toward personalized treatments that improve patient outcomes and reduce healthcare costs. Additionally, a global health technology and consumer electronics solutions company headquartered in the Netherlands highlighted the rising demand for user-friendly devices designed for home use. Our company’s expertise aligns seamlessly with the growing trends in personalized treatments and home healthcare solutions highlighted at the event.
Final Thoughts
The insights from AMDS 2024 suggest that the medical device industry is poised for significant transformation. Companies can redefine industry standards by embracing new technologies, adapting to regulatory changes, and exploring emerging opportunities.
At Johari MedTech (a Syrma SGS company), we are committed to being a trusted partner for driving advancements in the medical device industry. Leveraging the insights gained from AMDS 2024, we plan to expand our technical capabilities to meet the rising demand for next-generation medical devices. Our team intends to build on the valuable connections made at the summit to co-develop advanced solutions in diverse sectors, including diagnostics, critical care, and medical aesthetics. In addition, we are set to enhance our global presence by expanding operations across key markets to address the dynamic needs of our clients, ensuring reliable and cost-effective solutions.